Sigma Healthcare SIG.AX · AUD
Health Care · Health Care Providers & Services · ASX · 🇦🇺 Australia
2.85
+1.06%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Sigma Healthcare
Its shares trade on ASX under the ticker SIG.AX. It has been listed since 30 October 2002. In the fiscal year to 31 January 2026, it reported revenue of A$10.83bn and net income of A$709.2m. At that date it held total assets of A$8.91bn and shareholders' equity of A$5.00bn.
Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private label. The company is headquartered in Melbourne, Victoria. The company went IPO on 2002-10-30. The firm operates over 1,200 branded and independent stores, including pharmacy retail brands, such as Amcal, Guardian, PharmaSave, Chemist King and Discount Drug Stores. The company has partnership agreements to provide independent pharmacy support services to more than 500 independent pharmacies. Its Sigma Financial Services provide support services to help pharmacies better manage their finances; offers pharmacy finance referral program, and pharmacy fit-out finance with tailored bank support. The firm also operates online store to offer approximately 9,000 products to consumers. The company also operates Sigma Generics Program (SGP) to drive generic substitution and pharmacist profitability. The company also operates Sigma Resource Centre to provide customizable levels of support to suit the needs of all pharmacies, branded or independent.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 30 Oct 2002
- Employees
- 156
- Website
- sigmahealthcare.com.au ↗
Leadership
Pay as last reported
- Mr. Michael SammellsNon-Executive Chairman of the BoardA$461,085
- Mr. Vikesh RamsunderChief Executive Officer, Managing Director, Executive Director, since 2022A$3.4m
- Mr. Mark ConwayChief Financial OfficerA$486,262
- Ms. Kara McgowanGeneral Counsel, Company Secretary
- Ms. Annette CareyNon-Executive DirectorA$124,706
- Mr. Neville MitchellNon-Executive DirectorA$199,538
- Dr. Christopher RobertsNon-Executive DirectorA$47,680
- Ms. Kathryn SpargoNon-Executive DirectorA$174,883
- Mr. Gary WoodfordHead of Corporate Affairs
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 57
- Environment
- 65
- Social
- 73
- Governance
- 33
- Direct emissions (scope 1)
- 7.57 t
- Energy emissions (scope 2)
- 6,594 t
- Women in the workforce
- 64%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Strong market presence: Sigma Healthcare Ltd has established itself as a leading player in the healthcare industry.
- Diverse product portfolio: The company offers a wide range of pharmaceutical and medical products, catering to various customer needs.
- Strategic partnerships: Sigma Healthcare has forged strong partnerships with major suppliers, enabling them to access a diverse range of products and deliver value to customers.
- Broad distribution network: The company has an extensive distribution network that ensures efficient and timely delivery of products to pharmacies and hospitals.
- Strong financial position: Sigma Healthcare enjoys a stable financial position, which provides them with the resources to invest in growth opportunities and innovation.
Weaknesses
- Dependence on suppliers: Sigma Healthcare heavily relies on its suppliers for the availability of products, which exposes them to potential supply chain disruptions.
- Vulnerability to regulatory changes: The company operates in a highly regulated industry, making it susceptible to changes in government policies and regulations.
- Limited international presence: While Sigma Healthcare has a strong presence within the domestic market, their international reach is limited, potentially hindering expansion into global markets.
- Competitive market: The healthcare industry is highly competitive, and Sigma Healthcare faces competition from both traditional and online pharmacies, which could impact market share.
Opportunities
- Growing healthcare industry: With the increasing demand for healthcare products and services, Sigma Healthcare can capitalize on this opportunity to expand its customer base and market share.
- Technological advancements: The adoption of digital technologies in the healthcare sector opens up avenues for Sigma Healthcare to enhance operational efficiency and improve customer experience.
- Expansion into emerging markets: Exploring and entering emerging markets can provide Sigma Healthcare with new growth opportunities and access to a larger customer base.
Threats
- Economic fluctuations: Sigma Healthcare may be affected by economic downturns, which could impact consumer spending on healthcare products and services.
- Price competition: The presence of low-cost competitors within the industry may put pressure on Sigma Healthcare's pricing strategy.
- Technological disruption: Rapid advancements in technology may disrupt traditional distribution models, requiring Sigma Healthcare to adapt and invest in new systems and infrastructure.
- Regulatory challenges: Tightening of regulations or changes in government policies can impose compliance burdens on Sigma Healthcare and increase operational costs.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.